{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:41:06Z","timestamp":1773873666929,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":240,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.idcr.2023.e01890","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T02:02:19Z","timestamp":1693360939000},"page":"e01890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0179-6484","authenticated-orcid":false,"given":"Seowoong","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishiro","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ajisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2023.e01890_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","article-title":"Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies","volume":"12","author":"Lee","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.idcr.2023.e01890_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.26209","article-title":"Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy","volume":"96","author":"Dul\u00e9ry","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.idcr.2023.e01890_bib3","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1016\/j.clml.2021.07.004","article-title":"Resolution of one-year persisting COVID-19 pneumonia and development of immune thrombocytopenia in a follicular lymphoma patient with preceding rituximab maintenance therapy: a follow-up report and literature review of cases with prolonged infections","volume":"21","author":"Yasuda","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.idcr.2023.e01890_bib4","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2169\/internalmedicine.9136-21","article-title":"Prolonged COVID-19 in an immunocompromised patient treated with obinutuzumab and bendamustine for follicular lymphoma","volume":"61","author":"Ueda","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.idcr.2023.e01890_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijid.2020.12.050","article-title":"Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir","volume":"104","author":"Camprub\u00ed","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/23744235.2022.2028896","article-title":"Successful treatment with a short course of remdesivir in a case of prolonged COVID-19 in a lymphoma patient","volume":"54","author":"Kajova","year":"2022","journal-title":"Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib7","first-page":"8","article-title":"The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID- 19 in an Immunocompromised patient-a case study","author":"Sepulcri","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"Helleberg","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib9","doi-asserted-by":"crossref","first-page":"E1762","DOI":"10.1093\/cid\/ciaa1474","article-title":"Emerging RNA-dependent RNA polymerase mutation in a remdesivir-treated B-cell immunodeficient patient with protracted coronavirus disease 2019","volume":"73","author":"Martinot","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib10","first-page":"1","article-title":"Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab","author":"Franceschini","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.idcr.2023.e01890_bib11","first-page":"10","article-title":"Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration nirmatrelvir-ritonavir among outpatients with hematologic cancer","author":"Liu","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkac433","article-title":"Successful use of nirmatrelvir\/ritonavir in immunocompromised patients with persistent and\/or relapsing COVID-19","volume":"78","author":"Graziani","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2023.e01890_bib13","first-page":"59","article-title":"Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma","author":"Karata\u015f","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.idcr.2023.e01890_bib14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000521121","article-title":"Management of persistent SARS-CoV-2 infection in patients with follicular lymphoma","volume":"145","author":"Mart\u00ednez-Barranco","year":"2022","journal-title":"Acta Haematol"},{"key":"10.1016\/j.idcr.2023.e01890_bib15","first-page":"10","article-title":"Prolonged course of COVID-19-associated pneumonia in a B-cell depleted patient after rituximab","author":"Kos","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.idcr.2023.e01890_bib16","first-page":"11","article-title":"Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values","author":"Thornton","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.idcr.2023.e01890_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2023.01.040","article-title":"Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally","volume":"645","author":"Kawashima","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.idcr.2023.e01890_bib18","article-title":"Efficacy and safety of ensitrelvir in patients with mild-to-moderate coronavirus disease 2019 (COVID-19): the phase 2b part of a randomized, placebo-controlled, phase 2\/3 study","author":"Mukae","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/cid\/ciac847","article-title":"Dual antiviral therapy for persistent coronavirus disease 2019 and associated organizing pneumonia in an immunocompromised host","volume":"76","author":"Trottier","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01890_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18827","article-title":"Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection","author":"Peracchi","year":"2023","journal-title":"Br J Haematol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250923002147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250923002147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:06:27Z","timestamp":1761998787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250923002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":20,"alternative-id":["S2214250923002147"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01890","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01890"}}